286 related articles for article (PubMed ID: 15332220)
21. Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism.
Malberti F; Corradi B; Cosci P; Calliada F; Marcelli D; Imbasciati E
Am J Kidney Dis; 1996 Nov; 28(5):704-12. PubMed ID: 9158208
[TBL] [Abstract][Full Text] [Related]
22. MIBI scintigraphy, indicators of cell proliferation and histology of parathyroid glands in uraemic patients.
Custódio MR; Montenegro F; Costa AF; dos Reis LM; Buchpiguel CA; Oliveira SG; Noronha IL; Moysés RM; Jorgetti V
Nephrol Dial Transplant; 2005 Sep; 20(9):1898-903. PubMed ID: 15956063
[TBL] [Abstract][Full Text] [Related]
23. Contribution of early SPECT/CT to
García-Talavera P; Díaz-Soto G; Montes AA; Villanueva JG; Cobo A; Gamazo C; Ruiz MÁ; González-Selma ML
Rev Esp Med Nucl Imagen Mol; 2016; 35(6):351-357. PubMed ID: 27132216
[TBL] [Abstract][Full Text] [Related]
24. Has double-phase MIBI scintigraphy usefulness in the diagnosis of hyperparathyroidism?
Torregrosa JV; Palomar MR; Pons F; Sabater L; Gilabert R; Llovera J; Fernández-Cruz L
Nephrol Dial Transplant; 1998; 13 Suppl 3():37-40. PubMed ID: 9568818
[TBL] [Abstract][Full Text] [Related]
25. Dual-phase 99mTc-MIBI scintigraphy to assess calcimimetic effect in patients on haemodialysis with secondary hyperparathyroidism.
Fuster D; Torregrosa JV; Domenech B; Solà O; Martín G; Casellas J; Setoain X; Muxí A; Pons F
Nucl Med Commun; 2009 Nov; 30(11):890-4. PubMed ID: 19657304
[TBL] [Abstract][Full Text] [Related]
26. Dobutamine modulated Tc-99m MIBI scintigraphy in secondary hyperparathyroidism in uremic patients.
Quagliata A; López JJ; Guissoli P; Gambini JP; Hermida JC; Alonso O
Clin Nucl Med; 2007 Oct; 32(10):782-6. PubMed ID: 17885358
[TBL] [Abstract][Full Text] [Related]
27. Bone uptake of Tc-99m MIBI in patients with hyperparathyroidism.
Zhao Y; Wang Q
Ann Nucl Med; 2014 May; 28(4):349-55. PubMed ID: 24519437
[TBL] [Abstract][Full Text] [Related]
28. Two-phase scintigraphy with technetium 99m-sestamibi in patients with hyperparathyroidism due to chronic renal failure.
Muros MA; Bravo Soto J; López Ruiz JM; Rodríguez-Portillo M; Ramírez Navarro A; Bellón Guardia M; Perán F; Llamas-Elvira JM
Am J Surg; 2007 Apr; 193(4):438-42. PubMed ID: 17368284
[TBL] [Abstract][Full Text] [Related]
29. [Effect of calcitriol on secondary hyperparathyroidism].
Xu H; Zhang J; Cheng X; Zhou Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 38(9):920-4. PubMed ID: 24071691
[TBL] [Abstract][Full Text] [Related]
30. Advantages of pinhole collimator double-phase scintigraphy with 99mTc-MIBI in secondary hyperparathyroidism.
Fuster D; Depetris M; Torregrosa JV; Squarcia M; Paschoalin RP; Mayoral M; Granados U; Colletti PM; Rubello D; Pons F
Clin Nucl Med; 2013 Nov; 38(11):878-81. PubMed ID: 24089071
[TBL] [Abstract][Full Text] [Related]
31. Comparison of histological findings and parathyroid scintigraphy in hemodialysis patients with secondary hyperparathyroid glands.
Nishida H; Ishibashi M; Hiromatsu Y; Kaida H; Baba K; Miyake I; Ikedo H; Kato S; Fukami K; Iida S; Okuda S
Endocr J; 2005 Apr; 52(2):223-8. PubMed ID: 15863952
[TBL] [Abstract][Full Text] [Related]
32. Decreased blood lead levels after calcitriol treatment in hemodialysis patients with secondary hyperparathyroidism.
Lu KC; Wu CC; Ma WY; Chen CC; Wu HC; Chu P
Bone; 2011 Dec; 49(6):1306-10. PubMed ID: 21985997
[TBL] [Abstract][Full Text] [Related]
33. Preoperative parathyroid gland localization with technetium-99m sestamibi in secondary hyperparathyroidism.
Pons F; Torregrosa JV; Vidal-Sicart S; Sabater L; Fuster D; Fernández-Cruz L; Herranz R
Eur J Nucl Med; 1997 Dec; 24(12):1494-8. PubMed ID: 9391184
[TBL] [Abstract][Full Text] [Related]
34. Long-term effects of small doses of calcitriol in hemodialysis patients with moderate secondary hyperparathyroidism.
Vlassopoulos D; Noussias C; Revenas K; Hadjilouka-Mantaka A; Arvanitis D; Tzortzis G; Hadjiconstantinou V
Ren Fail; 1999 Mar; 21(2):199-207. PubMed ID: 10088180
[TBL] [Abstract][Full Text] [Related]
35. [Diagnosis of recurrent secondary hyperparathyroidism using double-phase 99m-Tc-MIBI gammagraphy after total parathyroidectomy with autotransplantation].
Fuster D; Torregrosa JV; Ortega M; Mas M; Martín F; Setoain FJ; Pons F
Nefrologia; 2002; 22(4):377-80. PubMed ID: 12369130
[TBL] [Abstract][Full Text] [Related]
36. Effective treatment of secondary hyperparathyroidism in hemodialysis patients by titration of intravenous calcitriol dosage.
Grekas D; Balaskas E; Kampouris H; Benos A; Konstantinou A; Sioullis A; Tourkantonis A
Clin Nephrol; 1999 Sep; 52(3):167-71. PubMed ID: 10499312
[TBL] [Abstract][Full Text] [Related]
37. Preoperative evaluation of hyperparathyroidism: the role of dual-phase parathyroid scintigraphy and ultrasound imaging.
Sukan A; Reyhan M; Aydin M; Yapar AF; Sert Y; Canpolat T; Aktas A
Ann Nucl Med; 2008 Feb; 22(2):123-31. PubMed ID: 18311537
[TBL] [Abstract][Full Text] [Related]
38. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism.
Park CW; Oh YS; Shin YS; Kim CM; Kim YS; Kim SY; Choi EJ; Chang YS; Bang BK
Am J Kidney Dis; 1999 Jan; 33(1):73-81. PubMed ID: 9915270
[TBL] [Abstract][Full Text] [Related]
39. Effects of calcitriol on type 5b tartrate-resistant acid phosphatase and interleukin-6 in secondary hyperparathyroidism.
Lu KC; Tseng CF; Wu CC; Yeung LK; Chen JS; Chao TY; Janckila AJ; Yam LT; Chu P
Blood Purif; 2006; 24(5-6):423-30. PubMed ID: 16888370
[TBL] [Abstract][Full Text] [Related]
40. Relation between technetium 99m-methoxyisobutylisonitrile accumulation and multidrug resistance protein in the parathyroid glands.
Yamaguchi S; Yachiku S; Hashimoto H; Kaneko S; Nishihara M; Niibori D; Shuke N; Aburano T
World J Surg; 2002 Jan; 26(1):29-34. PubMed ID: 11898030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
